Page last updated: 2024-10-23

azathioprine and Severe Dengue

azathioprine has been researched along with Severe Dengue in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Severe Dengue: A virulent form of dengue characterized by THROMBOCYTOPENIA and an increase in vascular permeability (grades I and II) and distinguished by a positive pain test (e.g., TOURNIQUET PAIN TEST). When accompanied by SHOCK (grades III and IV), it is called dengue shock syndrome.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carvalho, MA1
Dias, JT1
Satrapa, DA1
Silva, RG1
Machado, NC1

Other Studies

1 other study available for azathioprine and Severe Dengue

ArticleYear
Dengue Hemorrhagic Fever in a Child With Early-Onset Fistulizing Crohn Disease Under Infliximab and Azathioprine Treatment.
    Journal of pediatric gastroenterology and nutrition, 2016, Volume: 62, Issue:1

    Topics: Azathioprine; Child; Crohn Disease; Female; Gastrointestinal Agents; Humans; Immunocompromised Host;

2016